Literature DB >> 7972768

AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes.

P Vassallo1, C Matei, W D Heston, S J McLachlan, J A Koutcher, R A Castellino.   

Abstract

PURPOSE: To determine the value of magnetic resonance (MR) lymphography enhanced with AMI-227, a superparamagnetic reticuloendothelial-system-specific contrast agent, to distinguish normal and reactive from tumor-bearing lymph nodes.
MATERIALS AND METHODS: Mature male Copenhagen rats were inoculated with cell suspensions of R3327-MATLyLu rat prostate carcinoma (n = 16) or Complete Freund Adjuvant (n = 15) to generate ipsilateral popliteal lymph node metastases or lymphadenitis. At 12-14 days after inoculation, T1- and T2-weighted MR images of bilateral popliteal areas were obtained before and 24 hours after administration of AMI-227 (dose, 30 mumol Fe/kg). The contralateral popliteal nodes served as controls. Contrast-to-noise ratios (C/Ns) between the nodes and adjacent muscle were calculated in pre- and postcontrast images. Subsequently, bilateral popliteal nodes were excised.
RESULTS: AMI-227 resulted in decreased C/N in reactive nodes (T1-weighted, -186% +/- 90% [standard deviation]; T2-weighted, -205% +/- 96%) and normal nodes (n = 7) (T1-weighted, -306% +/- 82; T2-weighted, -350% +/- 96). C/N remained unchanged or increased (T1-weighted, 88% +/- 92; T2-weighted, 306% +/- 256) (P < .05).
CONCLUSION: Differences in AMI-227 uptake at MR imaging may help differentiate tumor-bearing from nontumor-bearing nodes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7972768     DOI: 10.1148/radiology.193.2.7972768

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  18 in total

Review 1.  Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  Sarah J Vinnicombe; Rodney H Reznek
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-23       Impact factor: 9.236

Review 2.  Imaging the lymphatic system: possibilities and clinical applications.

Authors:  Olivier Clément; Alain Luciani
Journal:  Eur Radiol       Date:  2004-03-09       Impact factor: 5.315

Review 3.  Magnetic resonance molecular imaging with nanoparticles.

Authors:  Gregory M Lanza; Patrick M Winter; Shelton D Caruthers; Anne M Morawski; Anne H Schmieder; Katherine C Crowder; Samuel A Wickline
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

4.  Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability.

Authors:  Stephan Metz; Ambros J Beer; Marcus Settles; Jaroslav Pelisek; René M Botnar; Ernst J Rummeny; Peter Heider
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-24       Impact factor: 2.357

Review 5.  Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications.

Authors:  Seyed Mohammadali Dadfar; Karolin Roemhild; Natascha I Drude; Saskia von Stillfried; Ruth Knüchel; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2019-01-11       Impact factor: 15.470

6.  Ferumoxtran-10-enhanced MR imaging of the bone marrow before and after conditioning therapy in patients with non-Hodgkin lymphomas.

Authors:  Stephan Metz; Stefanie Lohr; Marcus Settles; Ambros Beer; Klaus Woertler; Ernst J Rummeny; Heike E Daldrup-Link
Journal:  Eur Radiol       Date:  2005-11-12       Impact factor: 5.315

7.  Synergistic enhancement of iron oxide nanoparticle and gadolinium for dual-contrast MRI.

Authors:  Fan Zhang; Xinglu Huang; Chunqi Qian; Lei Zhu; Naoki Hida; Gang Niu; Xiaoyuan Chen
Journal:  Biochem Biophys Res Commun       Date:  2012-08-07       Impact factor: 3.575

8.  Magnetic resonance imaging of cells in experimental disease models.

Authors:  Naser Muja; Jeff W M Bulte
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2009-07       Impact factor: 9.795

9.  Ferumoxtran-10, a superparamagnetic iron oxide as a magnetic resonance enhancement agent for imaging lymph nodes: a phase 2 dose study.

Authors:  Patricia A Hudgins; Yoshimi Anzai; Marie R Morris; Maria A Lucas
Journal:  AJNR Am J Neuroradiol       Date:  2002-04       Impact factor: 3.825

10.  Positive contrast MR-lymphography using inversion recovery with ON-resonant water suppression (IRON).

Authors:  Grigorios Korosoglou; Lijun Tang; Dorota Kedziorek; Kenyatta Cosby; Wesley D Gilson; Evert-Jan Vonken; Michael Schär; David Sosnovik; Dara L Kraitchman; Robert G Weiss; Ralf Weissleder; Matthias Stuber
Journal:  J Magn Reson Imaging       Date:  2008-05       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.